SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper
Kurzübersicht für SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper (ABIN7478588)
Target
Alle SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Reactive with the NP of native SARS & MERS coronaviruses.
-
Kreuzreaktivität (Details)
- These antibodies are non-reactive with the following Coronavirus strains: 229E, NL63 & OC43.
-
Aufreinigung
- purified preparations consist of >90% pure mouse monoclonal antibody which has been purified from ascites fluid or culture medium by protein A chromatography or sequential differential precipitations.
-
Reinheit
- 90,00 %
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Working dilution must be determined by the user. Suggested starting ranges are 1:10-1:50 for IFA and 1:20-1:200 for ELISA.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100 μg/mL
-
Buffer
- The final preparation is formulated to a protein concentration of 100 μg/mL in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1 % sodium azide. No stabilizing proteins.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- should be stored at 2-8°C until ready for use.
-
-
- SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)
-
Andere Bezeichnung
- SARS-Coronavirus Nucleocapsid Protein
-
Substanzklasse
- Viral Protein
Target
-